HB STRATEGIES

Lobbying for BAYER U.S. LLC · Pharmaceutical and life sciences company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $90,000.00 income · posted Apr 18, 2026

Lobbying activity 3

Pharmacy

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Health Issues

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Agriculture

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.